Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and
appropriate therapy are essential. This update and revision of the global guideline for HAE …

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

Scientific and clinical progress together with the development of effective novel therapeutic
options has engendered multiple important changes in the diagnosis and management of …

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and
appropriate therapy are often unknown or not available for physicians and other health care …

Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …

This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …

Background Hereditary angioedema (HAE) is a rare, life-threatening genetic disorder
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …

Background The treatment of hereditary angioedema (HAE) has undergone dramatic
changes as newer medicines have become available in recent years. Optimal care of these …

Objective Hereditary angioedema (HAE) is a rare genetic disease characterized by long-
term recurrent attacks of subcutaneous or submucosal edema in different parts of the body …

Hereditary angioedema (HAE) is a rare disease that causes episodic attacks of
subcutaneous and submucosal edema, which can be painful, incapacitating, and potentially …